Passive and active drug targeting: drug delivery to tumors as an example.
about
Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacyEmerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systemsPhotodynamic therapy: one step ahead with self-assembled nanoparticlesTargeting anticancer drug delivery to pancreatic cancer cells using a fucose-bound nanoparticle approachTherapeutic efficacy of combining pegylated liposomal doxorubicin and radiofrequency (RF) ablation: comparison between slow-drug-releasing, non-thermosensitive and fast-drug-releasing, thermosensitive nano-liposomesCo-delivery of doxorubicin and SATB1 shRNA by thermosensitive magnetic cationic liposomes for gastric cancer therapyBiodegradable double-targeted PTX-mPEG-PLGA nanoparticles for ultrasound contrast enhanced imaging and antitumor therapy in vitroWhen 1+1>2: Nanostructured composites for hard tissue engineering applicationsDecafluorobutane as a phase-change contrast agent for low-energy extravascular ultrasonic imaging.Phase-change nanoparticles using highly volatile perfluorocarbons: toward a platform for extravascular ultrasound imagingNano delivers big: designing molecular missiles for cancer therapeutics.Advances in the field of nanooncology.Use of Nanotechnology to Develop Multi-Drug Inhibitors For Cancer TherapyLapatinib-incorporated lipoprotein-like nanoparticles: preparation and a proposed breast cancer-targeting mechanism.Liposomal nanostructures for photosensitizer delivery.Surface functionalization of doxorubicin-loaded liposomes with octa-arginine for enhanced anticancer activity.5-Fluorouracil derivatives: a patent review.Iron oxide nanoparticle-based magnetic resonance method to monitor release kinetics from polymeric particles with high resolutionAptamer CaCO3 nanostructures: a facile, pH-responsive, specific platform for targeted anticancer theranosticsImaging DNA damage in vivo using gammaH2AX-targeted immunoconjugatesTargeting extracellular DNA to deliver IGF-1 to the injured heartOn the mechanism of targeting of phage fusion protein-modified nanocarriers: only the binding peptide sequence mattersInhibition of colon cancer cell growth by nanoemulsion carrying gold nanoparticles and lycopene.The combined effect of encapsulating curcumin and C6 ceramide in liposomal nanoparticles against osteosarcoma.Virosomes of hepatitis B virus envelope L proteins containing doxorubicin: synergistic enhancement of human liver-specific antitumor growth activity by radiotherapy.EGFR-mediated intracellular delivery of Pc 4 nanoformulation for targeted photodynamic therapy of cancer: in vitro studies.Polymeric conjugates for drug deliveryThe effect of nanoparticle polyethylene glycol surface density on ligand-directed tumor targeting studied in vivo by dual modality imaging.Improved anti-glioblastoma efficacy by IL-13Rα2 mediated copolymer nanoparticles loaded with paclitaxel.Designing polymers with sugar-based advantages for bioactive delivery applicationsChallenges in design and characterization of ligand-targeted drug delivery systems.Advanced targeted nanomedicineAddressing challenges of heterogeneous tumor treatment through bispecific protein-mediated pretargeted drug delivery.Bioavailability of metalloporphyrin-based SOD mimics is greatly influenced by a single charge residing on a Mn siteApplication of liposomes in drug development--focus on gastroenterological targets.Targeted polymeric therapeutic nanoparticles: design, development and clinical translationEngineering nanomedicines for improved melanoma therapy: progress and promises.Applications of nanoparticle drug delivery systems for the reversal of multidrug resistance in cancer.Porous silicon nanocarriers for dual targeting tumor associated endothelial cells and macrophages in stroma of orthotopic human pancreatic cancers.Sigma-2 receptor ligand as a novel method for delivering a SMAC mimetic drug for treating ovarian cancer.
P2860
Q26826863-285E7B7B-533B-42A3-BA6C-9ABF46428127Q26996159-F7849284-3867-4BF1-88D1-74DA11479C65Q28083513-D79A0A2C-0826-4886-ADA9-3F0B7E3FE858Q28481264-BF35CB39-36EB-4ADB-93B3-B62A200D3034Q28538311-31D64EC3-8448-45AC-B44B-A70DAA0FDD1BQ28541628-7D937A81-6A84-43C4-9B64-AC309E5B56B2Q30360132-139C58CB-A690-4978-940C-37246888D853Q30368848-3CB5E923-3D5D-46FB-9423-D34BA3607F37Q30410631-8DE74316-0A93-4BC5-9846-055016D87559Q30458493-3523532B-D417-44AA-8C72-0743453564D6Q30470080-CC5DA9C3-1329-471D-A93B-90C7E8DABB1EQ30477604-963782D2-5B66-4D90-8BD4-3E352FF67F76Q33859472-29E3FDBE-AFB2-4D45-8D2A-76B306925F61Q33861915-E52FF17D-57DC-4757-83B8-467DA6718AA2Q34068206-5DFC857D-F6B0-4AA7-9FB9-E895E5DF5491Q34146337-9113B861-9AD1-4720-9877-B740D050C4F9Q34253978-4305E3F1-2537-4AD1-97B1-E657EA676BA3Q34379425-C2375E77-C058-45C1-9959-D392BB2025D2Q35068350-42AD9E14-8D57-4ED6-87CC-E2A71D35345AQ35087681-F32B141F-4F64-4843-84A3-F9CB3C40D3ACQ35113470-09A2448C-5EEB-4CA7-8B0B-321454767CBAQ35256650-29053DC3-EDC7-4420-B34F-7E372B5417F3Q35444840-C9FAFCCC-B4FE-464A-9B11-53743D781DD9Q35653799-BCEEA2C4-5AF0-454A-B6C9-83E22D74F5CEQ35804205-6756354E-8C85-435F-AC36-30F7C3D43396Q35851952-CC8666F6-5106-4603-BE60-E9C57D6AA8D8Q36029175-B9513BB0-CD96-44B3-8CC2-F04F1D653997Q36075868-9D857AEE-E10D-4B62-811D-78A7EF3098DBQ36280722-778DC00D-D347-4170-B7B3-534912F52B36Q36307576-288F3EB1-2985-4B34-975C-CF38847B4175Q36346851-F0F36FA6-9BEF-414E-80A6-2549897CBBC1Q36388931-3F37EB99-D291-4E23-9C11-A742C3EE7ADEQ36395999-7F657A48-D0ED-4B49-A57B-8C7CC3A9AD7DQ36406448-4DBAE93E-45FF-46C7-A6B6-3593B45863B1Q36758275-8482DD5E-A4EE-4AE9-87BE-4211B811A0F7Q36934007-29E0FAC8-D971-4BAB-97C1-3C493B37E57BQ36936646-8E824B9D-1A7A-4C6D-8EC9-FE37510070DCQ37002153-D0717717-E058-4229-AD20-E63CC054432EQ37187922-68219BB2-F0A4-4D06-9430-BCF0C92D3AA1Q37279268-E2AF1328-9AD5-40A3-A917-ACFC4E7119E5
P2860
Passive and active drug targeting: drug delivery to tumors as an example.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Passive and active drug targeting: drug delivery to tumors as an example.
@en
Passive and active drug targeting: drug delivery to tumors as an example.
@nl
type
label
Passive and active drug targeting: drug delivery to tumors as an example.
@en
Passive and active drug targeting: drug delivery to tumors as an example.
@nl
prefLabel
Passive and active drug targeting: drug delivery to tumors as an example.
@en
Passive and active drug targeting: drug delivery to tumors as an example.
@nl
P1476
Passive and active drug targeting: drug delivery to tumors as an example.
@en
P2093
Vladimir P Torchilin
P356
10.1007/978-3-642-00477-3_1
P577
2010-01-01T00:00:00Z